Binbin Cheng

1.1k total citations · 1 hit paper
37 papers, 809 citations indexed

About

Binbin Cheng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Binbin Cheng has authored 37 papers receiving a total of 809 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Oncology and 9 papers in Immunology. Recurrent topics in Binbin Cheng's work include Cancer Immunotherapy and Biomarkers (11 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (9 papers). Binbin Cheng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (11 papers), Protein Degradation and Inhibitors (9 papers) and Peptidase Inhibition and Analysis (9 papers). Binbin Cheng collaborates with scholars based in China and United States. Binbin Cheng's co-authors include Jianjun Chen, Yichang Ren, Hao Cao, Yao Xiao, Gang Li, Weien Yuan, Yao Liu, Jing Su, Yi Xing and Shuanghu Wang and has published in prestigious journals such as Journal of Medicinal Chemistry, Science Advances and Biochemical Pharmacology.

In The Last Decade

Binbin Cheng

34 papers receiving 799 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

HDAC-targeting epigenetic modulators for cancer immunotherapy

2024 58 citations Binbin Cheng, Yao Xiao et al. European Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Binbin Cheng China	15	422	404	184	181	43	37	809
Vincent Guerlavais United States	11	397 0.9×	214 0.5×	102 0.6×	66 0.4×	42 1.0×	22	650
Jeremy Griggs United Kingdom	8	210 0.5×	187 0.5×	97 0.5×	178 1.0×	46 1.1×	8	541
Shuaixiang Zhou China	14	333 0.8×	217 0.5×	81 0.4×	176 1.0×	47 1.1×	24	725
Marcin D. Tomala Poland	5	177 0.4×	304 0.8×	52 0.3×	123 0.7×	48 1.1×	6	446
Chunxia Huang China	15	231 0.5×	178 0.4×	127 0.7×	71 0.4×	14 0.3×	40	538
Dehua Lu China	16	311 0.7×	165 0.4×	67 0.4×	109 0.6×	59 1.4×	29	575
Merrina Anugraham Switzerland	7	582 1.4×	95 0.2×	159 0.9×	200 1.1×	79 1.8×	8	664
Haiyang Wang China	11	230 0.5×	262 0.6×	50 0.3×	164 0.9×	17 0.4×	23	553
Darby Schmidt United States	11	269 0.6×	142 0.4×	290 1.6×	189 1.0×	11 0.3×	18	787
Elisabetta Corna Italy	16	454 1.1×	339 0.8×	47 0.3×	69 0.4×	17 0.4×	35	726

Countries citing papers authored by Binbin Cheng

Since Specialization

Citations

This map shows the geographic impact of Binbin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Binbin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Binbin Cheng more than expected).

Fields of papers citing papers by Binbin Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Binbin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Binbin Cheng. The network helps show where Binbin Cheng may publish in the future.

Co-authorship network of co-authors of Binbin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Binbin Cheng. A scholar is included among the top collaborators of Binbin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Binbin Cheng. Binbin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Binbin, et al.. (2025). Research progress in DNA damage response (DDR)-targeting modulators: From hits to clinical candidates. European Journal of Medicinal Chemistry. 287. 117347–117347. 1 indexed citations

Tu, Xiaoyu, Wanfu Lin, Xiaofeng Zhai, et al.. (2025). Oleanolic acid inhibits M2 macrophage polarization and potentiates anti-PD-1 therapy in hepatocellular carcinoma by targeting miR-130b-3p-PTEN-PI3K-Akt signaling and glycolysis. Phytomedicine. 141. 156750–156750. 5 indexed citations

Cheng, Binbin, et al.. (2025). Research progress in bifunctional small molecules for cancer immunotherapy. European Journal of Medicinal Chemistry. 286. 117289–117289. 3 indexed citations

Liang, Shufang, Maoyong Fu, Yehui Shi, et al.. (2025). Arsenic trioxide enhances the inhibitory effect of lenvatinib on hepatocellular carcinoma through HMOX1-mediated ferroptosis. International Immunopharmacology. 167. 115656–115656.

Cheng, Binbin, et al.. (2025). Rational design of NAMPT-based dual inhibitors with improved drug-like and pharmacokinetic properties for cancer treatment. European Journal of Medicinal Chemistry. 297. 117966–117966.

Hu, Zhihao, Shuqing Li, Haiqi He, et al.. (2025). Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy. Journal of Medicinal Chemistry. 68(5). 5426–5454. 3 indexed citations

Li, Ling, et al.. (2024). Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies. Biomedicine & Pharmacotherapy. 178. 117218–117218. 14 indexed citations

Cheng, Binbin, et al.. (2024). Overview of class I HDAC modulators: Inhibitors and degraders. European Journal of Medicinal Chemistry. 276. 116696–116696. 12 indexed citations

Ni, Bin, et al.. (2024). Overview of the PRMT6 modulators in cancer treatment: Current progress and emerged opportunity. European Journal of Medicinal Chemistry. 279. 116857–116857. 1 indexed citations

10.

Cheng, Binbin, et al.. (2024). HDAC-targeting epigenetic modulators for cancer immunotherapy. European Journal of Medicinal Chemistry. 265. 116129–116129. 58 indexed citations breakdown →

11.

Cheng, Binbin, et al.. (2024). Recent advances in developing targeted protein degraders. European Journal of Medicinal Chemistry. 284. 117212–117212. 8 indexed citations

12.

Cheng, Binbin, et al.. (2024). Small molecule inhibitors targeting PD-L1, CTLA4, VISTA, TIM-3, and LAG3 for cancer immunotherapy (2020–2024). European Journal of Medicinal Chemistry. 283. 117141–117141. 11 indexed citations

13.

Cheng, Binbin, et al.. (2024). Recent progress in the development of hypoxia-inducible factor 2α (HIF-2α) modulators: Inhibitors, agonists, and degraders (2009–2024). European Journal of Medicinal Chemistry. 275. 116645–116645. 2 indexed citations

14.

Cheng, Binbin, et al.. (2022). Recent advances in DDR (DNA damage response) inhibitors for cancer therapy. European Journal of Medicinal Chemistry. 230. 114109–114109. 78 indexed citations

15.

Cao, Hao, Binbin Cheng, Ting Liu, & Jianjun Chen. (2021). Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment. Biochemical Pharmacology. 188. 114522–114522. 17 indexed citations

16.

Cheng, Binbin, Yichang Ren, Xiaoge Niu, et al.. (2020). Discovery of Novel Resorcinol Dibenzyl Ethers Targeting the Programmed Cell Death-1/Programmed Cell Death–Ligand 1 Interaction as Potential Anticancer Agents. Journal of Medicinal Chemistry. 63(15). 8338–8358. 66 indexed citations

17.

Cheng, Binbin, et al.. (2020). Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatment. European Journal of Medicinal Chemistry. 213. 113058–113058. 28 indexed citations

18.

Cheng, Binbin, Wei Wang, Xiaoge Niu, et al.. (2020). Discovery of Novel and Highly Potent Resorcinol Dibenzyl Ether-Based PD-1/PD-L1 Inhibitors with Improved Drug-like and Pharmacokinetic Properties for Cancer Treatment. Journal of Medicinal Chemistry. 63(24). 15946–15959. 43 indexed citations

19.

Ouyang, Mingxing, Lei Lei, R Harrison, et al.. (2019). Biophysical basis underlying dynamic Lck activation visualized by ZapLck FRET biosensor. Science Advances. 5(6). eaau2001–eaau2001. 28 indexed citations

20.

Cao, Hui, et al.. (2010). Mating type factors of Lentinus squarrosulus.. Shiyongjun xuebao. 17(4). 5–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact